Cargando…

TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth

Early studies indicated that TR4 nuclear receptor (TR4) may play a key role to modulate the prostate cancer progression, its potential linkage to liver cancer progression, however, remains unclear. Here we found that higher TR4 expression in hepatocellular carcinoma (HCC) cells might enhance the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jiliang, Lin, Hui, Li, Gonghui, Jin, Ren-An, Shi, Liang, Chen, Mingming, Chang, Chawnshang, Cai, Xiujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077999/ https://www.ncbi.nlm.nih.gov/pubmed/27050071 http://dx.doi.org/10.18632/oncotarget.8525

Ejemplares similares

TR(4) nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression
por: Jin, Ren’an, et al.
Publicado: (2018)

Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
por: Hu, Linyi, et al.
Publicado: (2019)

TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression
por: Lin, Shin-Jen, et al.
Publicado: (2015)

Sorafenib with ASC‐J9(®) synergistically suppresses the HCC progression via altering the pSTAT3‐CCL2/Bcl2 signals
por: Xu, Junjie, et al.
Publicado: (2016)

Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals
por: Ding, Xianfan, et al.
Publicado: (2015)

Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression
por: Shi, Hangchuan, et al.
Publicado: (2019)

Correction to: Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating acrophages with alteration of the TIMP-1/MMP2/MMP9 signals
por: Ding, Xianfan, et al.
Publicado: (2020)

TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells
por: Lin, Shin-Jen, et al.
Publicado: (2015)

Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis
por: Lin, Shin-Jen, et al.
Publicado: (2012)

TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals
por: Qiu, Xiaofu, et al.
Publicado: (2015)

The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals
por: Xu, Junjie, et al.
Publicado: (2016)

Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation
por: Yan, Shian-Jang, et al.
Publicado: (2012)

The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status()()
por: Lin, Shin-Jen, et al.
Publicado: (2015)

Metformin Inhibits Nuclear Receptor TR4–Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
por: Kim, Eungseok, et al.
Publicado: (2011)

Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT‐20 cells
por: Xia, Liqun, et al.
Publicado: (2021)

The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice
por: Collins, Loretta L, et al.
Publicado: (2011)

ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling
por: Tian, Hao, et al.
Publicado: (2021)

Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression
por: Chou, Fu-Ju, et al.
Publicado: (2019)

Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021)

Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer
por: Bortot, Barbara, et al.
Publicado: (2020)

JDP2 is directly regulated by ATF4 and modulates TRAIL sensitivity by suppressing the ATF4–DR5 axis
por: Engler, Máté János, et al.
Publicado: (2020)

Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells
por: Shi, Zhong, et al.
Publicado: (2019)

The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
por: Chen, Daishi, et al.
Publicado: (2017)

Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization
por: Mukherjee, Shravanti, et al.
Publicado: (2020)

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
por: Li, Jiarui, et al.
Publicado: (2012)

Molecular mechanism of acquired drug resistance in the EGFR‐TKI resistant cell line HCC827‐TR
por: Yu, Tao, et al.
Publicado: (2020)

p53‐independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells
por: Sharma, Kanika, et al.
Publicado: (2018)

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells
por: Liu, Haiyan, et al.
Publicado: (2009)

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
por: Zhang, Meng, et al.
Publicado: (2021)

Structures of human TR4(LBD)–JAZF1 and TR4(DBD)–DNA complexes reveal the molecular basis of transcriptional regulation
por: Liu, Yunlong, et al.
Publicado: (2023)

Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC
por: Wu, Chuanxing, et al.
Publicado: (2021)

Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma: Mff promotes cisplatin resistance in HCC
por: Li, Xiaoliang, et al.
Publicado: (2022)

An ATF(24) peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
por: Zhai, Bingtao, et al.
Publicado: (2020)

Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation
por: Zhang, Chao, et al.
Publicado: (2017)

The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer
por: Liu, Bianjiang, et al.
Publicado: (2020)

Gold Nanopeanuts as Prospective Support for Cisplatin in Glioblastoma Nano-Chemo-Radiotherapy
por: Depciuch, Joanna, et al.
Publicado: (2020)

LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription
por: Lin, Zhongjie, et al.
Publicado: (2020)

RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2014)

BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin
por: Endo, Shino, et al.
Publicado: (2021)

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations
por: Chi, Chenfei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pi2eat1j7lccqj1aesgelsnc4